extremely significantP <0.001
The obese group showed a significant decrease ( P value<0.05) after 24 weeks of insulin therapy and an extremely significant decrease ( P <0.001) in TNF-α and IL-6 levels after 48 weeks of therapy.
The obese group showed a significant decrease ( P value<0.05) after 24 weeks of insulin therapy and an extremely significant decrease ( P <0.001) in TNF-α and IL-6 levels after 48 weeks of therapy.